Nasal Spray Live Attenuated Influenza Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Nasal Spray Live Attenuated Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nasal Spray Live Attenuated Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nasal Spray Live Attenuated Influenza Vaccine Overall Market Size
2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size: 2022 VS 2029
2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nasal Spray Live Attenuated Influenza Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Nasal Spray Live Attenuated Influenza Vaccine Players in Global Market
3.2 Top Global Nasal Spray Live Attenuated Influenza Vaccine Companies Ranked by Revenue
3.3 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Companies
3.4 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Companies
3.5 Global Nasal Spray Live Attenuated Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nasal Spray Live Attenuated Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nasal Spray Live Attenuated Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Nasal Spray Live Attenuated Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Nasal Spray Live Attenuated Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Markets, 2022 & 2029
4.1.2 Trivalent Flu Vaccine
4.1.3 Quadrivalent Flu Vaccine
4.2 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2023
4.3.2 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Sales, 2024-2029
4.3.3 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Public Health Agency
5.1.5 Other
5.2 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2023
5.3.2 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Sales, 2024-2029
5.3.3 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2023
6.3.2 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Sales, 2024-2029
6.3.3 By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2029
6.4.3 US Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.4.4 Canada Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.4.5 Mexico Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2029
6.5.3 Germany Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.5.4 France Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.5.5 U.K. Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.5.6 Italy Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.5.7 Russia Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.5.9 Benelux Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2029
6.6.3 China Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.6.4 Japan Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.6.5 South Korea Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.6.7 India Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2029
6.7.3 Brazil Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.7.4 Argentina Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales, 2018-2029
6.8.3 Turkey Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.8.4 Israel Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
6.8.6 UAE Nasal Spray Live Attenuated Influenza Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.1.4 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Pasteur Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.2.4 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 CSL
7.3.1 CSL Company Summary
7.3.2 CSL Business Overview
7.3.3 CSL Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.3.4 CSL Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 CSL Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.4.4 Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.5.4 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Serum Institute
7.6.1 Serum Institute Company Summary
7.6.2 Serum Institute Business Overview
7.6.3 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.6.4 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Serum Institute Key News & Latest Developments
7.7 Fluenz Tetra
7.7.1 Fluenz Tetra Company Summary
7.7.2 Fluenz Tetra Business Overview
7.7.3 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.7.4 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Fluenz Tetra Key News & Latest Developments
7.8 BioDiem
7.8.1 BioDiem Company Summary
7.8.2 BioDiem Business Overview
7.8.3 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.8.4 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 BioDiem Key News & Latest Developments
7.9 FluMist
7.9.1 FluMist Company Summary
7.9.2 FluMist Business Overview
7.9.3 FluMist Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.9.4 FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 FluMist Key News & Latest Developments
7.10 ChangChun High & New Technology
7.10.1 ChangChun High & New Technology Company Summary
7.10.2 ChangChun High & New Technology Business Overview
7.10.3 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.10.4 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 ChangChun High & New Technology Key News & Latest Developments
7.11 BCHT Biotechnology
7.11.1 BCHT Biotechnology Company Summary
7.11.2 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Business Overview
7.11.3 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Major Product Offerings
7.11.4 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 BCHT Biotechnology Key News & Latest Developments
8 Global Nasal Spray Live Attenuated Influenza Vaccine Production Capacity, Analysis
8.1 Global Nasal Spray Live Attenuated Influenza Vaccine Production Capacity, 2018-2029
8.2 Nasal Spray Live Attenuated Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Nasal Spray Live Attenuated Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nasal Spray Live Attenuated Influenza Vaccine Supply Chain Analysis
10.1 Nasal Spray Live Attenuated Influenza Vaccine Industry Value Chain
10.2 Nasal Spray Live Attenuated Influenza Vaccine Upstream Market
10.3 Nasal Spray Live Attenuated Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nasal Spray Live Attenuated Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Nasal Spray Live Attenuated Influenza Vaccine in Global Market
Table 2. Top Nasal Spray Live Attenuated Influenza Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Nasal Spray Live Attenuated Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasal Spray Live Attenuated Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), 2024-2029
Table 16. By Application ? Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), 2024-2029
Table 21. By Region ? Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales, (K Units), 2024-2029
Table 46. Sanofi Pasteur Company Summary
Table 47. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 48. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Pasteur Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 52. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. CSL Company Summary
Table 55. CSL Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 56. CSL Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. CSL Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 60. Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 64. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Serum Institute Company Summary
Table 67. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 68. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Serum Institute Key News & Latest Developments
Table 70. Fluenz Tetra Company Summary
Table 71. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 72. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Fluenz Tetra Key News & Latest Developments
Table 74. BioDiem Company Summary
Table 75. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 76. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. BioDiem Key News & Latest Developments
Table 78. FluMist Company Summary
Table 79. FluMist Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 80. FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. FluMist Key News & Latest Developments
Table 82. ChangChun High & New Technology Company Summary
Table 83. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 84. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. ChangChun High & New Technology Key News & Latest Developments
Table 86. BCHT Biotechnology Company Summary
Table 87. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product Offerings
Table 88. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. BCHT Biotechnology Key News & Latest Developments
Table 90. Nasal Spray Live Attenuated Influenza Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Nasal Spray Live Attenuated Influenza Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Nasal Spray Live Attenuated Influenza Vaccine Production by Region, 2018-2023 (K Units)
Table 93. Global Nasal Spray Live Attenuated Influenza Vaccine Production by Region, 2024-2029 (K Units)
Table 94. Nasal Spray Live Attenuated Influenza Vaccine Market Opportunities & Trends in Global Market
Table 95. Nasal Spray Live Attenuated Influenza Vaccine Market Drivers in Global Market
Table 96. Nasal Spray Live Attenuated Influenza Vaccine Market Restraints in Global Market
Table 97. Nasal Spray Live Attenuated Influenza Vaccine Raw Materials
Table 98. Nasal Spray Live Attenuated Influenza Vaccine Raw Materials Suppliers in Global Market
Table 99. Typical Nasal Spray Live Attenuated Influenza Vaccine Downstream
Table 100. Nasal Spray Live Attenuated Influenza Vaccine Downstream Clients in Global Market
Table 101. Nasal Spray Live Attenuated Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nasal Spray Live Attenuated Influenza Vaccine Segment by Type in 2022
Figure 2. Nasal Spray Live Attenuated Influenza Vaccine Segment by Application in 2022
Figure 3. Global Nasal Spray Live Attenuated Influenza Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Nasal Spray Live Attenuated Influenza Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nasal Spray Live Attenuated Influenza Vaccine Revenue in 2022
Figure 9. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 23. US Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 37. China Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Nasal Spray Live Attenuated Influenza Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Nasal Spray Live Attenuated Influenza Vaccine by Region, 2022 VS 2029
Figure 54. Nasal Spray Live Attenuated Influenza Vaccine Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
